The Science of Certainty
Gubra enables you to progress your preclinical development for metabolic disorders with more certainty than any other research partner. We offer highly specialized services within five main disease areas.
NASH
Benefit from our extensive know-how in NASH and test your compound in our validated DIO NASH mouse models.
Gubra response measures to corona virus/covid-19
During the global coronavirus outbreak, Gubra’s key priority is to help the authorities in limiting spread of disease and protect our employees and their families, while at the same time safeguard a continued supply of research services to our partners and customers. The situation is continually evolving, but currently we are not experiencing any constraints and our study activities are running according to plans.
We have worked out detailed contingency plans for situations like this including inventory and staffing policy/plans that serves to maintain a continuity in deliveries.
Blockbuster webinars
Webinar: Lost in translation – how to improve the translatability of rodent models of diabetic kidney disease
Senior scientist Mette Viberg Østergaard introduces to the challenges of using current rodent models of diabetic kidney disease in drug discovery and development. Mette then presents an example of how translatability may be improved in a model of diabetic kidney disease in the setting of type 2 diabetes and hypertension.
Release time and duration: November 2020, 23 minutes
Webinar: Imaging diabetes using light sheet microscopy
In this webinar, principal scientist and biologist Jacob Hecksher-Sørensen talks about how to label the beta cells and image the whole pancreas, how to quantify the beta cell volume in mouse models of Type 1 and Type 2 diabetes, and lastly, Jacob takes us down new avenues imaging the nerves and vasculature.
Release time and duration: October 2020, 17 minutes
Upcoming Events
News
Neurodegenerative diseases
– a customized service
With a strong academic background in neuroscience and neurostereology we have conducted several preclinical studies of neurodegenerative diseases, including Parkinson and Alzheimers Disease.
Do you want to be part of a great team aiming high? Join us.
Our ambition is that Gubra is a place where talented people are empowered to put their competencies and passion into play every day. We work as a team to make a difference for people with serious metabolic diseases.
